Cargando…

Elevated Derived Neutrophil-to-Lymphocyte Ratio Corresponds With Poor Outcome in Patients Undergoing Pre-Operative Chemotherapy in Muscle-Invasive Bladder Cancer

Background: Platinum-based pre-operative chemotherapy (POC) for muscle-invasive bladder cancer (MIBC) increases the complete pathological response rate at cystectomy and improves overall survival. However, 60% of MIBC patients still has muscle-invasive disease at cystectomy despite POC. Therefore, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Kessel, Kim E.M., de Haan, Lorraine M., Fransen van de Putte, Elisabeth E., van Rhijn, Bas W.G., de Wit, Ronald, van der Heijden, Michiel S., Zwarthoff, Ellen C., Boormans, Joost L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2016
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969684/ https://www.ncbi.nlm.nih.gov/pubmed/27500202 http://dx.doi.org/10.3233/BLC-160055

Ejemplares similares

Limited Funds for Bladder Cancer Research and What Can We Do About It
por: Boormans, Joost L., et al.
Publicado: (2016)

A reported 20-gene expression signature to predict lymph node-positive disease at radical cystectomy for muscle-invasive bladder cancer is clinically not applicable
por: van Kessel, Kim E. M., et al.
Publicado: (2017)

Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis
por: de Jong, Joep J., et al.
Publicado: (2019)

The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder
por: van Doeveren, Thomas, et al.
Publicado: (2020)

Prospective bladder cancer infrastructure for experimental and observational research on bladder cancer: study protocol for the ‘trials within cohorts’ study ProBCI
por: Richters, Anke, et al.
Publicado: (2021)

FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy
por: Kompier, Lucie C., et al.
Publicado: (2010)

Selection of Microsatellite Markers for Bladder Cancer Diagnosis without the Need for Corresponding Blood
por: van Tilborg, Angela A. G., et al.
Publicado: (2012)

Cationic amphiphilic drugs as potential anticancer therapy for bladder cancer
por: van der Horst, Geertje, et al.
Publicado: (2020)

Urinary peptide panel for prognostic assessment of bladder cancer relapse
por: Krochmal, Magdalena, et al.
Publicado: (2019)

Down-staging (<pT2) of urothelial cancer at cystectomy after the diagnosis of detrusor muscle invasion (pT2) at diagnostic transurethral resection (TUR): is prediction possible?
por: Beukers, Willemien, et al.
Publicado: (2012)

Hospital volume is associated with postoperative mortality after radical cystectomy for treatment of bladder cancer
por: Richters, Anke, et al.
Publicado: (2021)

PD-L1 expression in urothelial bladder cancer varies more among specimen types than between companion assays
por: de Jong, Joep J., et al.
Publicado: (2021)

Detecting primary bladder cancer using delayed (18)F-2-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography imaging after forced diuresis
por: Mertens, Laura S, et al.
Publicado: (2012)

Short-term outcome after cystectomy: comparison of early oral feeding in an enhanced recovery protocol and feeding using Bengmark nasojejunal tube
por: Voskuilen, C. S., et al.
Publicado: (2017)

The bladder cancer immune micro-environment in the context of response to immune checkpoint inhibition
por: van Dorp, Jeroen, et al.
Publicado: (2023)

Induction therapy with ipilimumab and nivolumab followed by consolidative chemoradiation as organ-sparing treatment in urothelial bladder cancer: study protocol of the INDIBLADE trial
por: Stockem, C.F., et al.
Publicado: (2023)

Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines
por: Tilborg, A A G van, et al.
Publicado: (1999)

Bladder Recurrence Following Upper Tract Surgery for Urothelial Carcinoma: A Contemporary Review of Risk Factors and Management Strategies
por: Mertens, Laura S., et al.
Publicado: (2023)

Two Patients with Urachal Cancer with Multifocal Adenocarcinoma Recurrences in the Urothelium of the Prostatic and Penile Urethra
por: Stokkel, Laura E., et al.
Publicado: (2021)

Ex vivo assays to predict enhanced chemosensitization by hyperthermia in urothelial cancer of the bladder
por: van den Tempel, Nathalie, et al.
Publicado: (2018)

Hyperthermic Intravesical Chemotherapy for BCG Unresponsive Non-Muscle Invasive Bladder Cancer Patients
por: de Jong, Joep J., et al.
Publicado: (2018)

Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer
por: van der Vos, K. E., et al.
Publicado: (2020)

Circulating tumour cells to drive the use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer
por: Beije, N., et al.
Publicado: (2022)

Correspondence
por: Van Goidtsnoven, E.
Publicado: (1898)

The influence of thermo-chemotherapy on bladder tumours: an immunohistochemical analysis
por: van der Heijden, Antoine G., et al.
Publicado: (2007)

Pelvic lymph node dissection for cervical or bladder cancer: embedding residual fat tissue offers no added value
por: Vaneman, Jasmijn, et al.
Publicado: (2023)

Reduce bladder cancer recurrence in patients treated for upper urinary tract urothelial carcinoma: The REBACARE-trial
por: van Doeveren, T., et al.
Publicado: (2018)

Treating benign ureteroenteric strictures: 27-year experience comparing endourological techniques with open surgical approach
por: van Son, M. J., et al.
Publicado: (2018)

Neutrophil-Mediated Phagocytosis of Staphylococcus aureus
por: van Kessel, Kok P. M., et al.
Publicado: (2014)

Survival outcomes of patients with muscle-invasive bladder cancer according to pathological response at radical cystectomy with or without neo-adjuvant chemotherapy: a case–control matching study
por: van Ginkel, Noor, et al.
Publicado: (2022)

Consuming media, consuming food: investigating concurrent TV viewing and eating using a 7-d time use diary survey
por: Alblas, Monique C, et al.
Publicado: (2023)

In-depth investigation of the molecular pathogenesis of bladder cancer in a unique 26-year old patient with extensive multifocal disease: a case report
por: Zuiverloon, Tahlita CM, et al.
Publicado: (2010)

A Multicenter Retrospective Cohort Series of Muscle-invasive Bladder Cancer Patients Treated with Definitive Concurrent Chemoradiotherapy in Daily Practice
por: de Ruiter, Ben-Max, et al.
Publicado: (2022)

Sarcopenia as a comorbidity‐independent predictor of survival following radical cystectomy for bladder cancer
por: Mayr, Roman, et al.
Publicado: (2018)

Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer
por: Patel, K. M., et al.
Publicado: (2017)

The influence of multidisciplinary team meetings on treatment decisions in advanced bladder cancer
por: Walraven, Janneke E.W., et al.
Publicado: (2022)

Optimization of Preoperative Lymph Node Staging in Patients with Muscle-Invasive Bladder Cancer Using Radiomics on Computed Tomography
por: Starmans, Martijn P. A., et al.
Publicado: (2022)

Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections
por: van Puffelen, Jelmer H, et al.
Publicado: (2023)

Exercise intensity modulates capillary perfusion in correspondence with ACE I/D modulated serum angiotensin II levels
por: van Ginkel, Sander, et al.
Publicado: (2015)

Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer
por: Pagliarulo, Fabio, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b4gi0tv978ut7b7m8r6pk7ucho